首页> 外文OA文献 >Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

【2h】

Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

机译：Cladribine片剂在复发延长多发性硬化症患者中的安全性和有效性：清晰度研究的随机扩展试验结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Gavin Giovannoni; Per Soelberg Sorensen; Stuart Cook; Kottil Rammohan; Peter Rieckmann; Giancarlo Comi; Fernando Dangond; Abidemi K Adeniji; Patrick Vermersch;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study [J] . Giovannoni Gavin, Sorensen Per Soelberg, Cook Stuart, Multiple sclerosis: clinical and laboratory research . 2018,第12期

机译：Cladribine片剂在复发延伸患者患者中的安全性和有效性：清晰度研究的随机扩展试验结果
2. Efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis (RRMS) in the 120-week extension to the CLARITY study [J] . Giovannoni Gavin, Comi Giancarlo, Cook Stuart, Multiple sclerosis: clinical and laboratory research . 2018,第2期

机译：在澄清研究的120周延伸中延长多发性硬化（RRMS）患者克拉酮胺片剂的疗效
3. Efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis (RRMS) in the 120-week extension to the CLARITY study [J] . Giovannoni Gavin, Comi Giancarlo, Cook Stuart, Multiple sclerosis: clinical and laboratory research . 2018,第2期

机译：在澄清研究的120周延伸中延长多发性硬化（RRMS）患者克拉酮胺片剂的疗效
4. Microstructural Modulations in the Hippocampus Allow to Characterizing Relapsing-Remitting Versus Primary Progressive Multiple Sclerosis [C] . Lorenza Brusini, Ilaria Boscolo Galazzo, Muge Akinci, International Workshop on Brain-Lesion;Medical Image Computing and Computer Assisted Intervention Conference . 2020

机译：海马中的微观结构调制允许表征复发 - 延长与初级进步多发性硬化
5. An investigation of early relapsing-remitting multiple sclerosis patients using diffusion tensor imaging and spectroscopy. [D] . Zaini, Wan Hazlin. 2013

机译：使用扩散张量成像和光谱法对早期复发缓解型多发性硬化症患者进行调查。
6. Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study [O] . Giancarlo Comi, Stuart Cook, Kottil Rammohan, 2018

机译：克拉屈滨片对复发缓解型多发性硬化症患者MRI活动结局的长期影响：CLARITY Extension研究
7. Assessing the Long-Term Effectiveness of Cladribine vs. Placebo in the Relapsing-Remitting Multiple Sclerosis CLARITY Randomized Controlled Trial and CLARITY Extension Using Treatment Switching Adjustment Methods [O] . Helen Bell Gorrod, Nicholas R. Latimer, Doris Damian, 2019

机译：使用治疗开关调整方法评估覆盖覆盖覆盖多发性硬化透明度随机对照试验和清晰度延伸的克拉替韦氏菌与安慰剂的长期效果

Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

著录项

引文网络

相似文献

相关主题

期刊订阅